ID

12992

Description

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder; ODM derived from: https://clinicaltrials.gov/show/NCT00001381

Link

https://clinicaltrials.gov/show/NCT00001381

Keywords

Versions (1)
  1. 1/10/16 1/10/16 -
Uploaded on

January 10, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Bladder Neoplasms NCT00001381

English

Eligibility Bladder Neoplasms NCT00001381

1 forms  
Criteria
Description

Criteria

histologically confirmed superficial transitional cell carcinoma of the bladder pathologically staged as tis, ta, or t1. visible tumors at time of treatment not required. no metastatic disease or muscle invasion.
Description

Transitional cell carcinoma of the bladder, tumor stage

Data type

boolean

Alias
UMLS CUI [1]
C0279680
UMLS CUI [2]
C1300072
clinically useful pretreatment bladder function required.
Description

Pretreatment, bladder function

Data type

boolean

Alias
UMLS CUI [1]
C3539076
UMLS CUI [2]
C0232840
no significant prostatic obstructive symptoms associated with impaired or incomplete bladder emptying.
Description

prostatic obstructive symptoms, bladder emptying

Data type

boolean

Alias
UMLS CUI [1]
C0268889
UMLS CUI [2]
C0429805
no active urinary tract infection.
Description

urinary tract infection

Data type

boolean

Alias
UMLS CUI [1]
C0042029
at least 1 course of prior standard intravesical therapy required.
Description

intravesical therapy

Data type

boolean

Alias
UMLS CUI [1]
C0444473
at least 4 weeks since intravesical treatment, with resolution of any local or systemic toxicity.
Description

time since intravesical treatment, toxicities

Data type

boolean

Alias
UMLS CUI [1]
C0444473
UMLS CUI [2]
C0013221
age: 18 and over.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
performance status: ecog 0 or 1.
Description

ecog

Data type

boolean

Alias
UMLS CUI [1]
C1520224
wbc at least 3,300;
Description

wbc

Data type

boolean

Alias
UMLS CUI [1]
C0023508
hemoglobin at least 10 g/dl.
Description

hemoglobin

Data type

boolean

Alias
UMLS CUI [1]
C0019046
bilirubin no greater than 1.5 mg/dl;
Description

bilirubin

Data type

boolean

Alias
UMLS CUI [1]
C1278039
ast and alt no greater than 2 times normal.
Description

ast and alt

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
renal: creatinine no greater than 1.5 mg/dl.
Description

creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0201976
medically able to undergo cystoscopy.
Description

cystoscopy

Data type

boolean

Alias
UMLS CUI [1,1]
C0010702
UMLS CUI [1,2]
C0085732
no pregnant women.
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
Back to the top of the page

Similar models

Eligibility Bladder Neoplasms NCT00001381

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Transitional cell carcinoma of the bladder, tumor stage
Item
histologically confirmed superficial transitional cell carcinoma of the bladder pathologically staged as tis, ta, or t1. visible tumors at time of treatment not required. no metastatic disease or muscle invasion.
boolean
C0279680 (UMLS CUI [1])
C1300072 (UMLS CUI [2])
Pretreatment, bladder function
Item
clinically useful pretreatment bladder function required.
boolean
C3539076 (UMLS CUI [1])
C0232840 (UMLS CUI [2])
prostatic obstructive symptoms, bladder emptying
Item
no significant prostatic obstructive symptoms associated with impaired or incomplete bladder emptying.
boolean
C0268889 (UMLS CUI [1])
C0429805 (UMLS CUI [2])
urinary tract infection
Item
no active urinary tract infection.
boolean
C0042029 (UMLS CUI [1])
intravesical therapy
Item
at least 1 course of prior standard intravesical therapy required.
boolean
C0444473 (UMLS CUI [1])
time since intravesical treatment, toxicities
Item
at least 4 weeks since intravesical treatment, with resolution of any local or systemic toxicity.
boolean
C0444473 (UMLS CUI [1])
C0013221 (UMLS CUI [2])
age
Item
age: 18 and over.
boolean
C0001779 (UMLS CUI [1])
ecog
Item
performance status: ecog 0 or 1.
boolean
C1520224 (UMLS CUI [1])
wbc
Item
wbc at least 3,300;
boolean
C0023508 (UMLS CUI [1])
hemoglobin
Item
hemoglobin at least 10 g/dl.
boolean
C0019046 (UMLS CUI [1])
bilirubin
Item
bilirubin no greater than 1.5 mg/dl;
boolean
C1278039 (UMLS CUI [1])
ast and alt
Item
ast and alt no greater than 2 times normal.
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
creatinine
Item
renal: creatinine no greater than 1.5 mg/dl.
boolean
C0201976 (UMLS CUI [1])
cystoscopy
Item
medically able to undergo cystoscopy.
boolean
C0010702 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
pregnancy
Item
no pregnant women.
boolean
C0032961 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial